6th Oncology Biomarkers
 Register 3 for the price of 2 with the coupon code rcdvb!
Dear Colleague,

GTC is proud to present the 2nd Inflammatory & Immunological Biomarkers as part of our Biomarker Summit 2013, to be held on March 20-22, 2013 in San Francisco, California. This conference will discuss a wide range of issues in the biomarker field specific to inflammatory and immunological therapeutic areas. Topics such as novel approaches to biomarker discovery, enabling technologies, regulatory and reimbursement trends and the development of companion diagnostics will be discussed. Specific disease areas include cardiovascular disease, metabolic diseases, arthritis, autoimmune diseases, kidney / renal disease and inflammatory bowel disease. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Below is an agenda outline for this conference:


March 20th

Plenary Keynote Session

March 21st

Breakout: Inflammatory / Immunological Biomarkers

Vascular & Metabolic Biomarkers
- Cardiovascular Disease
- Diabetes
- Atherosclerosis
- Myocardial Injury
- Stroke
Biomarkers in Allergy & Autoimmune Diseases
- Rheumatoid Arthritis
- SLE
- Asthma & COPD
- IBD
Development of Immunotherapy for Cancer

Mar 22nd

General Session

Regulatory & Reimbursement Updates in Biomarker & Diagnostic Development
New Technologies & Novel Approaches to Biomarker Development
+ Panel Discussion
Companion Diagnostics Development & Partnering Strategies
+ Panel Discussion

The 2nd Inflammatory & Immunological Biomarkers Conference will be running concurrently with the following tracks:

2nd Neurological Biomarkers
6th Oncology Biomarkers


Call for Papers!
To be considered for an oral presentation, please submit an abstract here by February 20, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.

Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or spex@gtcbio.com for more information.

Best Regards,
Organizing Committee

See you in San Francisco!
GOLD SPONSOR
SILVER SPONSORS
SUPPORTING SPONSORS
MEDIA PARTNER
Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!

What Past Delegates Said About the Event:

"This was a very good conference that brought together scientist and managers from industry and academia, presenting the progress, chances and challenges in the biomarker arena. I liked in particular the size of the conference which was very good for networking."
 - Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer Pharma AG

“I found that participation at this conference was highly rewarding. Its size was ideal for networking, and the program was a perfect mix of disease areas and novel technologies.”
 - Mark Broenstrup Sanofi-Aventis Deutschland GmbH, R&D Diabetes Division, Biomarker&Diagnostics

“The smaller size of these meetings relative to the mega-conferences we often attend is a welcome change! There were many opportunities to meet and talk with other attendees one-on-one, and to my mind, that is one of the great benefits of attending a meeting. The quality of the presentations was universally high."
 - Mark Duncan, Professor of Medicine, School of Medicine, Endocrinology, Metabolism, and Diabetes, University of Colorado

“A very informative 2 day conference on Biomarkers featuring a good selection of speakers and topics – the best biomarker meeting I’ve attended in a while. The size of the conference was great for networking. I made a lot of good contacts there and learned a lot from the discussions I had with other attendees. The location was great as well.”
 - Paul Whittaker, PhD, Director, Respiratory Diseases Area, Novartis Institutes for Biomedical Research

"The GTCbio conference put me in touch with a focused group of researchers from all walks interested in advancing the same science. I've never connected with so many potential research partners in such a short time."
 - Timothy R. Church, Ph.D., Professor, Division of Environment Health Science, University of Minnesota